Haoxuan Wang

11 Patents

• US125595082026

  Semi-saturated Bicyclic Derivatives and Related Uses

  MOMA Therapeutics, Inc.

  0 cites
• US124284252025

  Heterocyclic Compounds as Triggering Receptor Expressed on Myeloid Cells 2 Agonists and Methods of Use

  VIGIL NEUROSCIENCE, Inc.

  0 cites
• US124212492025

  Inhibitors of APOL1 and Methods of Using Same

  Vertex Pharmaceuticals Incorporated

  0 cites
• US123196912025

  Heterocyclic Compounds as Triggering Receptor Expressed on Myeloid Cells 2 Agonists and Methods of Use

  Vigil Neuroscience, Inc.

  0 cites
• US122524892025

  Heterocyclic Compounds as Triggering Receptor Expressed on Myeloid Cells 2 Agonists and Methods of Use

  Vigil Neuroscience, Inc.

  0 cites
• US122408392025

  Cyclobutyl Dihydroquinoline Sulfonamide Compounds

  AMGEN Inc.

  0 cites
• US119127112024

  Heterocyclic Compounds as Triggering Receptor Expressed on Myeloid Cells 2 Agonists and Methods of Use

  VIGIL NEUROSCIENCE, Inc.

  0 cites
• US118846752024

  Heterocyclic Compounds as Triggering Receptor Expressed on Myeloid Cells 2 Agonists and Methods of Use

  VIGIL NEUROSCIENCE, Inc

  0 cites
• US118664462024

  Inhibitors of APOL1 and Methods of Using Same

  Vertex Pharmaceuticals Incorporated

  0 cites
• US117186172023

  Heterocyclic Compounds as Triggering Receptor Expressed on Myeloid Cells2 Agonists and Methods of Use

  Vigil Neuroscience, Inc.

  0 cites
• US116083442023

  Heterocyclic Compounds as Triggering Receptor Expressed on Myeloid Cells 2 Agonists and Methods of Use

  VIGIL NEUROSCIENCE, Inc.

  0 cites